Jingwen Li

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

University of Arkansas

Also affiliated: Hebei Medical University (2021); Fujian Normal University (2016–2026); Tongji University (2024); Nanjing Agricultural University (2018–2025); Fujian Medical University (2025–2026); National Institutes of Health (2016); Union Hospital (2020–2025); Tianjin University of Science and Technology (2009); Beijing University of Posts and Telecommunications (2022–2024); Tianjin Normal University (2025); Xinjiang Medical University (2020–2025); Shandong University (2012); Harbin Medical University (2012–2023); China Pharmaceutical University (2016–2020); Yantai University (2020–2021); Xiamen University (2022); Jilin University (2013–2025); Chinese Academy of Sciences (2016–2023); Peking University (2015–2018); Huazhong Agricultural University (2016–2022); Hubei University of Chinese Medicine (2024); Sichuan University (2023–2025); Shanghai Chest Hospital (2021); First Affiliated Hospital of Xinjiang Medical University (2020–2025); University of Jinan (2020–2022); Zhengzhou University (2025); University of Oxford (2019); West China Hospital of Sichuan University (2023–2025); Liuzhou Maternal and Child Health Hospital (2018); Nanjing Children's Hospital (2020); Foundation for Human Potential (2019); Tianjin Anding Hospital (2025); Second Hospital of Hebei Medical University (2021); Third Affiliated Hospital of Harbin Medical University (2017); Shanghai Institutes for Biological Sciences (2016); Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2022–2025); Shanghai Advanced Research Institute (2023); Hubei University of Arts and Science (2017–2022); Xiangyang Central Hospital (2017–2022); Center for Excellence in Molecular Cell Science (2016); Wuhan Union Hospital (2020–2024); Stomatology Hospital (2018); Key Laboratory of Nuclear Radiation and Nuclear Energy Technology (2025); Curtiss-Wright (United States) (2019); Jilin Medical University (2020–2024); Science Oxford (2019); National Institute for Communicable Disease Control and Prevention (2025); Ministry of Agriculture and Rural Affairs (2024–2025); Jilin Agricultural University (2021–2024); First Affiliated Hospital of Harbin Medical University (2012–2023); Qingdao Institute of Bioenergy and Bioprocess Technology (2016–2020); Xijing Hospital (2025); Tongji Hospital (2024); China University of Petroleum, East China (2024); Union Hospital (2020–2024); University of Chinese Academy of Sciences (2018); State Key Laboratory of Microbial Technology (2012); Wuhan University of Science and Technology (2025–2026); Huazhong University of Science and Technology (2018–2025); Hubei University (2024); Nanjing Medical University (2020–2025); Chongqing Medical University (2020–2023); Nanjing University (2020); South China University of Technology (2022); Nanchang Hangkong University (2025); Air Force Medical University (2009–2025)

Faculty Researcher

27 h-index 124 pubs 2,804 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Jingwen Li's research investigates molecular mechanisms underlying various biological processes, with a focus on gene expression regulation and metabolic pathways in both plants and animals. Li has published work examining the role of m6A reader IGF2BP2 in regulating glutamine metabolism as a potential therapeutic target in acute myeloid leukemia. Other studies include the analysis of bZIP gene families in lotus and the functional study of NnbZIP36 in anthocyanin synthesis, as well as the investigation of CsWRKY13, a WRKY transcription factor in *Camellia sinensis*, involved in lignin biosynthesis.

Additional research areas include exploring the interplay between mitochondria and the cytoskeleton in cardiovascular diseases, and the Pin1/YAP pathway's role in matrix stiffness-induced epithelial-mesenchymal transition driving cervical cancer metastasis. Li has also contributed to understanding astrocyte-to-neuron reprogramming in Parkinson's disease treatment and the mechanisms of salt tolerance in *Sophora alopecuroides* through combined transcriptomic and metabolomic analysis. The researcher's scholarly output is reflected in an h-index of 27, with 123 total publications and 2,763 citations.

Metrics

h-index: 27
Publications: 124
Citations: 2,804

Selected Publications

High density multi-electrode array electrophysiology in awake animals (2026)

WORLD SCIENTIFIC eBooks DOI OpenAlex
When random variation results in functional significance (2023)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex